Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.5K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

411
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
411
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-I: Introduction01:29

Asthma-I: Introduction

2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

305
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
305

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Severe asthma and remission prospects in Europe (SHARP): insights from a multicentre observational study based on the European Severe Asthma Registry.

The Lancet. Respiratory medicine·2026
Same author

Clinical Features of Cellular Senescence Pathways in Severe Asthma.

Allergy·2026
Same author

Single-cell transcriptomics of granulocytes in asthma and atopic diseases.

Frontiers in molecular biosciences·2026
Same author

Asthma exacerbation profile of benralizumab for severe eosinophilic asthma (the BenRex study): a multicentre, prospective cohort study.

The Lancet. Respiratory medicine·2026
Same author

Clinical phenotypes of difficult-to-treat and mild asthma defined by cluster analysis.

Respiratory research·2026
Same author

Natural History of Alternaria Sensitisation and Association With Asthma and Rhinitis From Childhood to Adulthood.

Allergy·2026

相关实验视频

Updated: Jul 7, 2025

Methodology for Sputum Induction and Laboratory Processing
13:28

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

27.6K

轻度喘在表型上与难以治疗的喘有什么不同?

Jennifer Naftel1, Heena Mistry1,2,3,4,5, Frances Ann Mitchell4

  • 1National Institute for Health Research (NIHR) Southampton Biomedical Research Centre at University Hospital Southampton NHS Foundation Trust, Southampton, UK.

Journal of asthma and allergy
|December 25, 2023
PubMed
概括

轻度喘通常是早期发作的,其特点是2型炎症和常见的伴随性疾病,如焦虑和抑郁症. 早期评估可以防止疾病发展为严重疾病.

关键词:
困难的喘 困难的喘轻度喘 轻度喘是什么意思多重病态性多重病态性这是一种2型炎症.

更多相关视频

Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

40.3K
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

31.9K

相关实验视频

Last Updated: Jul 7, 2025

Methodology for Sputum Induction and Laboratory Processing
13:28

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

27.6K
Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

40.3K
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

31.9K

科学领域:

  • 肺部病理学 肺部病理学
  • 免疫学 免疫学 免疫学
  • 流行病学 流行病学

背景情况:

  • 轻度喘表型的研究不足,尽管它代表了大多数喘病例.
  • 这项研究旨在描述轻度喘,并将其与难以治疗的喘进行比较.

研究的目的:

  • 为了广泛描述轻度喘表型.
  • 将轻度喘的特征与难以治疗的喘进行比较.

主要方法:

  • 使用相同的方法评估了两个现实世界成年队列:困难喘的韦塞克斯喘队列 (WATCH) 和来自严重喘表观遗传学 (EOSA) 研究的轻度喘队列.
  • 数据包括临床问卷,人体测量,过敏和肺功能测试,以及生物样本 (血液和唾液).

主要成果:

  • 轻度喘主要是早期发作的,与2型 (T2) 炎症 (亚托皮,高分数呼出的氧化 (FeNO),乙氨酸性) 和保存的肺功能有关.
  • 在轻度喘中观察到伴随性疾病 (抑郁症,焦虑症) 和当前吸烟者的高患病率 (20.9%) .
  • 轻度喘与困难喘共享T2高的炎症和亚托皮,但中性粒细胞数量较低,肺功能保留.

结论:

  • 轻度喘的特点是早期发病,T2高的炎症,目前的吸烟以及显著的多病症.
  • 对轻度喘患者进行全面的早期评估,可以防止疾病发展为严重疾病.